Health Letter Volume Index

January 1997  -  January 2013

Order today

The price of an annual subscription (12 issues) is $18.00. You may also order back issues, which are available for $3.00 each. If you have questions about Health Letter, please call (202) 588-1000 and ask to speak with a representative from the Health Research Group.

Ordering by credit card

Unfortunately, it is not currently possible to order the Health Letter online. Call Member Services at (202) 588-1000 to order by credit card. Public Citizen accepts Visa, MasterCard, American Express and Discover.

Ordering by check

If you would rather pay by check, mail a check payable to Public Citizen to:

Health Letter
1600 20th Street NW
Washington, DC 20009 


January 2013, V29#1

  • Dietary Supplements Offer Little to No Benefit and May Be Harmful
  • Consensus on Iran Sanctions Cripples Iranian Health Sector
  • Pay for Performance: Does it Backfire for Doctors and Hospitals?
  • Health Letter Issue Index, 2012
  • Product Recalls
  • Outrage: Court Allows Big Tobacco to Hide the Graphic Dangers of Smoking

December 2012, V28#12

  • Fungal Meningitis Outbreak Highlights the Dangers of Compounding Pharmacies
  • As Online Drug Promotion Proliferates, Regulations Lag Behind
  • A single-Payer System, Not the ACA, Is the Remedy for the National Health Crisis
  • Product Recalls
  • Outrage: Top Five Examples of Overdiagnosis and Unnecessary Treatment

November 2012, V28#11

  • The American Medical Association and Its Dubious Revenue Streams
  • Angioplasty Offers Little Benefit for Low-Risk Patients
  • What You Should Know About Radon in Your Home
  • Product Recalls
  • Outrage: Evidence of the Damaging, Expensive Results of Privatizing Medicare

October 2012, V28#10

  • To Nap or Not to Nap
  • Dangerous Lack of Evidence Characterizes Prescription Drug Use in Children
  • Product Recalls
  • Outrage: Deficiencies of the Texas Medical Board

September 2012, V28#9

  • Choosing Wisely Project
  • Biased Data Can Lead to Substandard Drug Treatment
  • Bereavement: A Look at the Grieving Process And How to Cope With Loss
  • Product Recalls
  • Outrage: Substandard Doctors Should Not Treat Louisiana Prisoners

August 2012, V28#8

  • Financial Disclosure Requirements Delayed By Obama Administration
  • Public Citizen Fights for an End To Double Standard on Drug-Label Warnings
  • Product Recalls
  • Outrage: Profiting from Obamacare

July 2012, V28#7

  • Underrepresentation of the Elderly In Randomized Controlled Trials
  • Measuring Blood Pressure in Both Arms Could Help Predict Risks
  • FDA’s About-Face on Financial Conflicts of Interest
  • Obama Administration Sacrifices Children To Keep Agribusiness Happy
  • Preventing Heat-Induced Death and Illness
  • Product Recalls
  • Outrage: Medical Center Shares Patient Information With Fundraiser

June 2012, V28#6

  • Ranking of State Medical Board Serious Disciplinary Actions, 2009-2011
  • Product Recalls
  • Outrage: The Personal Face of Inadequate Doctor Discipline

May 2012, V28#5

  • States in the Spotlight as Single-Payer Resurfaces in Mainstream Discourse
  • Wide Variation in Rates of Second Breast Cancer Surgery
  • Nondrug Treatments for Neck Pain Better Than Medications
  • Product Recalls
  • Outrage: FDA Helps Companies Exploit Patients With Alzheimer’s Disease

April 2012, V28#4

  • Industry Lobbies to Weaken Medical Device Oversight
  • Scientific Fraud on the Rise: Its Impact on Patients and Research
  • Chronic Fatigue Syndrome: A Mystery Disease
  • Product Recalls
  • Outrage: Treating Sick Rich Folks

March 2012, V28#3

  • Osteoporosis Screening Needed Only Every 5 to 15 Years for Most Older Women
  • The Jungle: Meatpacking Workers, 100 Years Later
  • Being the Ghost in the Machine: A Medical Ghostwriter’s Personal View
  • Product Recalls
  • Outrage: Dangers of Overdiagnosis and Overtreatment

February 2012, V28#2

  • Florida Sanctions Top Medicaid Prescribers — But Only After a Shove
  • Product Recalls
  • Outrage: American Red Cross Violations

  • January 2012, V28#1

    • Child Labor: Alive and Well on American ‘Farms’
    • A More Perfect Union
    • Product Recalls
    • Health Letter Issue Index, 2011
    • Outrage: 50 Million Uninsured in the U.S. Equals 50,000+ Avoidable Deaths a Year

    • December 2011, V27#12

    • Doctor Experience Linked With Risk of Death From Carotid Artery Stenting Procedures
    • Medical-Device Approval Process Flawed, Dangerous for Patients
    • Product Recalls
    • Outrage: More Despicable Drug-Industry Behavior

    November 2011, V27#11

    • Obama Administration Refuses to Protect Doctors-in-Training From Dangerous Work Shifts
    • The Origins and Progress of Public Citizen’s Health Research Group: The First 40 Years
    • Product Recalls
    • Outrage: For Big Pharma, Crime Pays

    October 2011, V27#10

    • Workers Die From Extreme Heat, With Little Government Action
    • Second Opinions for Surgery: Avoiding Unnecessary Operations, Deaths and Expenses
    • Doctors Avoid Penalties in Suits Against Medical Firms
    • Product Recalls
    • Outrage: Having 50 Million Uninsured Americans Is Bad Enough, But…

    September 2011, V27#9

    • Proton Pump Inhibitors: Dangerous and Habit-Forming Heartburn Drugs
    • Preventing Diabetes on a Budget
    • Product Recalls
    • Outrage: Profiting from Disasters

    August 2011, V27#8

    • Governor Brown, Address the Poor Performance of California’s State Medical Board
    • Product Recalls
    • Outrage: Further Arguments for Eliminating the Private U.S. Health Insurance Industry

    July 2011, V27#7

    • Criminalizing the Seriously Mentally Ill: Two Decades Later
    • Criminalizing the Seriously Mentally Ill: The Abuse of Jails as Mental Hospitals
    • Product Recalls
    • Outrage: Hope for Delaware Emerges After Disaster for Its Children

    June 2011, V27#6

    • Ranking of State Medical Board Serious Disciplinary Actions, 2008-2010
    • How Does the Medical Industry Influence Patient Care?
    • Emails Show Drug Company Used Third-Party Medical Groups to Influence Regulators, Undercut Rivals
    • Product Recalls
    • Outrage: Remove Dangerous Alzheimer’s Drug — Aricept 23 — from the Market Immediately

    May 2011, V27#5

    • Losing Weight Safely and Effectively
    • Fourteen Years of Deceptive Television Drug Advertising
    • Product Recalls
    • Outrage: Unreliable Alzheimer’s Diagnoses

    April 2011, V27#4

    • Experts Who Write Highly Influential Clinical Practice Guidelines Have Significant Conflicts of Interest
    • Many Patients Undergo Unnecessary Invasive Cardiac Procedures
    • 10 Best Funded and 10 Worst Funded States in Providing Government Health Insurance Assistance
    • The Few, The Proud, The Thin
    • Inadequate NJBME Action Against Physicians Disciplined by Hospitals
    • Product Recalls
    • National Cancer Institute's Helpline: A Valuable, Underused Resource
    • Outrage: Patient Advocacy Groups and Drug Company Funding

    March 2011, V27#3

    • Patients at Risk: Medical Boards Fail to Discipline Almost 6,000 Physicians With Hospital Sanctions
    • Beware of Fraudulent ‘Dietary Supplements’
    • Proud, Safe Gun Owners Want Their Right to Bear Arms Privately
    • Our Unsafe Health Care System Is the Issue, Not Caps on Tort Settlements
    • Product Recalls
    • Outrage: Atomic (Nuclear) Power

    February 2011, V27#2

    • Breast Implants and Cancer Revisited: Plastic Surgeons Cover Up New Evidence of Human Cancer From Implants
    • National Cancer Institute’s Helpline: A Valuable, Underused Resource
    • Pharma’s War on Kids
    • Product Recalls
    • Outrage: War’s Adverse Impacts

    January 2011, V27#1

    • Can Drugs Make Americans Lose Weight? Not Likely
    • Aspirin-Induced Reye’s Syndrome: A Preventable Cause of Death
    • Health Letter Volume Index, 2010
    • Product Recalls
    • If a Drug Is New, Does That Make It Better?
    • Cholera in Haiti: A Look From the Trenches
    • Outrage: Governor Scott of Florida

    December 2010, V26#12

    • Treating the Common Cold (Without Making Yourself Sicker)
    • Skin Cancer Doesn’t Discriminate (Suggestions to Prevent Skin Cancer)
    • Lesbian, Gay and Bisexual Teens Singled Out For Punishment: Study in Leading Pediatric Journal Finds Unfair Treatment Nationwide
    • Early Stage Breast Cancer: More or Fewer Psychological Problems after More or Less Surgery
    • Thirteen Dirty Big Pharma Tricks That Rip You Off and Risk Your Health for Profit
    • Product Recalls
    • Outrage: Pharmaceutical Industry Is Biggest Defrauder of the Federal Government under the False Claims Act, New Public Citizen Study Finds

    November 2010, V26#11

    • Know When Antibiotics Work
    • HHS Report Is a Wake-Up Call to Fix National Patient Safety Crisis
    • The Risks of Tranquility
    • Product Recalls
    • Outrage: Holding Executives Accountable for Corporate Wrongdoing

    October 2010, V26#10

    • In the Public Interest — Abuses From the ‘Merchant Class’
    • Television Leads to Obese Children
    • Nine Essential Steps for Regulating Your Blood Pressure
    • Product Recalls
    • Outrage: U.S. Troops: More Deaths Related to Prescription Drugs

    September 2010, V26#9

    • OSHA Must Regulate Resident Physician Work Hours
    • Why Are Troops Killing Themselves?
    • Second Opinions for Surgery: Avoiding Unnecessary Operations, Deaths and Expenses
    • Product Recalls
    • Outrage: The Health Insurance Industry

    August 2010, V26#8

    • JAMA Survey Finds Doctors Unwilling to Report Negligent Peers
    • Cracks in FDA’s Medical Device Approval Process Allow Unproven Devices to Slip Through
    • In the Public Interest
    • To Mitch McConnell: We’re Already Rationing Care
    • Guidelines for the Perplexed
    • Practical Diabetes Tips for the Budget-Conscious
    • Product Recalls
    • Outrage: Don’t Get Sick in July

    July 2010, V26#7

    • Public Strongly Supports Substantially Reducing Work Hours for Resident Physicians, New Research Finds
    • Patient Safety Advocates Give Plan to Reform Medical Residency a Failing Grade
    • 10 Things You Need to Know About Healthcare Reform
    • A Doctor’s Word: Deciphering the New Mammography Guidelines
    • Product Recalls
    • Remembering the Flexner Report as a Drug Firm Pays $520 Million for Misleading Marketing
    • Outrage: They Said What?!

    June 2010, V26#6

    • FDA-Sanctioned International Diabetes Drug Trial Is Unethical and Dangerous, Must Be Stopped
    • Severely Mentally Ill More Likely to Be in Jails Than Hospitals, Report Shows
    • Product Recalls
    • A Doctor’s Word: How to Keep Your Blood Pressure Down
    • Outrage: Crime in the Pharma Suites

    May 2010, V26#5

    • Obama’s Reform: No Cure for What Ails Us
    • Guide to Avoiding Unnecessary Cesarean Sections in New York State
    • Health, Life Insurers Hold $1.88 Billion in Fast-Food Stocks
    • Product Recalls
    • Outrage: The Continuing Saga of Avandia: Paid Cheerleaders for the Drug

    April 2010, V26#4

    • Misprescribing and Overprescribing of Drugs
    • Ten Rules for Safer Drug Use
    • Product Recalls
    • Outrage: FDA Cautious on Food Safety, Reckless on Drug Safety

    March 2010, V26#3

    • Patient Safety Advocates Launch Campaign to Reduce Resident Physician Fatigue, Boost Patient Safety
    • Letter to the ACGME RE: Optimizing Medical Resident Schedules to Improve Patient Safety
    • The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences
    • What You Should Know About Low Back Pain
    • What You Should Know About Migraine
    • Product Recalls
    • Outrage: “Botox Injections Helpful for Depression?”

    February 2010, V26#2

    • Harvard Researchers: Health Information Technology Savings Will Only Occur With a Single-Payer Health System
    • Morton Mintz: Taking Aim at Insurance Execs’ Pay
    • Neonatal Circumcision for HIV Prevention: Cost, Culture and Behavioral Considerations
    • Health and Disease in People over 85: Despite Disease, Disability is Low
    • Product Recalls
    • Outrage: Everybody In, Nobody Out (That Means Immigrants Too!)

    January 2010, V26#1

    • Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
    • Health Letter Volume Index, 2009
    • Opposition to Prophylactic Removal of Third Molars (Wisdom Teeth)
    • Product Recalls
    • Outrage: Tamiflu? More Like Scamiflu!



    December 2009, V25#12

    • What Happened in Health Care in 2009
    • The Price We Pay for Uninsurance
    • Analysis of USPSTF 2009 Revised Breast Cancer Screening Recommendations
    • Product Recalls
    • Outrage: The Case of Neurontin: Skewed Research in the Service of Selling

    November 2009, V25#11

    • Health Reform: Where Will the Money Come From?
    • Product Recalls
    • Harvard Study Finds Nearly 45,000 Excess Deaths Annually Linked to Lack of Health Coverage
    • Outrage: AHIP’s Actuarial Acrobatics

    October 2009, V25#10

    • The Uninsured in the United States: What the Rise to 46.3 Million Means
    • Public Citizen Proposes Basic Patient Safety Reforms that Would Save 85,000 Lives and $35 Billion a Year
    • A Review of Homeopathy
    • Product Recalls
    • Health Debate or Health Charade?
    • Outrage: Drug Company Inducements to Doctors: Not Par for the Course

    September 2009, V25#9

    • Obama Administration Must Make Disciplinary Records of Nurses, Health Workers Available to Hospitals, Nursing Homes
    • Letter Urging Secretary Sebelius to Provide Hospitals and Nursing Homes Access to Names of Disciplined Nurses and Other Health Workers
    • A Call to Action: Why We Need Medical Resident Work Hour Reform
    • Product Recalls
    • Are We Now Twice as Sad? The Drug Industry and Doctors Think We Are!
    • Outrage: Ghostly Prescriptions

    August 2009, V25#8

    • Dr. Sidney Wolfe’s Testimony before Subcommittee on Health at Hearing on Health Insurance
    • Dr. Steffie Woolhandler’s Testimony before Health Subcommittee at Hearing on Health Insurance
    • Letter to the Editor of the Washington Post Regarding the Coverage of the Recent Congressional Hearing on Single-Payer
    • Ineffectual Medical Treatments Misleadingly Produce “Good” Results
    • Product Recalls
    • Outrage: Medical Publisher Offers Bribes for Writing Favorable Book Reviews

    July 2009, V25#7

    • Q & A on the Current Health Debate: What Does a ‘Public Plan Option’ Mean and Why Does Public Citizen Oppose it?
    • Hospitals Drop the Ball on Physician Oversight
    • A Dictionary of Health Policy Terms, Part III
    • Product Recalls
    • Outrage: Language Matters: Poor Communication Can Mean Poor Health Care

    June 2009, V25#6

    • Vermont’s Pharmaceutical Laws Move Toward Fuller Disclosure
    • What is Comparative Effectiveness Research, and Why is it Being Badmouthed?
    • Intro to Comparative Health Systems
    • Product Recalls
    • Outrage: A Coalition of the Scared

    May 2009, V25#5

    • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2006-2008
    • Product Recalls
    • Outrage: Psychoprostitution

    April 2009, V25#4

    • Stretching the TARP to Cover Health Care
    • Bereavement: A Look at the Grieving Process and How to Cope with Loss
    • Product Recalls
    • How Much Is A Year of Your Life Worth?
    • WARNING: MRI Scans May Burn Patients Wearing Transdermal Drug Patches
    • Outrage: High Deductibles for Limited Eligibles

    March 2009, V25#3

    • Massachusetts’ Plan: A Failed Model for Health Care Reform
    • Product Recalls
    • Having Health Insurance Does Not Mean Having Health Care
    • Public Hospitals, Community Clinics Suffering Under Massachusetts Health Care Reform
    • Outrage: Ending the Insanity of Failed State Health Insurance Reforms

    February 2009, V25#2

    • Our Perfectly Designed U.S. Healthcare System
    • Public Citizen Endorses Single Payer National Health System, Joins Leadership Conference for Guaranteed Health Care
    • U.S. Inmates Suffer from Chronic Illness and Poor Access to Health Care
    • Informed Consent and Shared Decision-Making
    • Product Recalls
    • Outrage: “Morning After” Contraception Too Difficult to Get

    January 2009, V25#1

    • Single Payer Health Care in Taiwan: Borrowing Ideas, Improving on Medicare
    • Health Letter Volume Index, 2008
    • Indulgence and Innovation in Medical Care
    • Product Recalls
    • Smokeless Tobacco: Rebranding Nicotine, Repackaging Death
    • Outrage: Full Body Scams: Not Your Source for Peace of Mind


      

    December 2008, V24#12

    • In Case You Missed It: What Happened in Health in 2008
    • Calculating Your Risk of Death from Disease and Accidents
    • Product Recalls
    • Outrage: Is the Uterus a Pre-Existing Condition?

    November 2008, V24#11

    • The Uninsured in the United States: What the Drop to 45.7 Million Means
    • Pharma Should Not Foot the Bill for Your Doctor’s Continuing Medical Education
    • Weighing Conscience Protection Against a Patient’s Right to Information
    • Product Recalls
    • Outrage: Mongering Diseases to Hawk Pills: The Case of Fibromyalgia

    October 2008, V24#10

    • A Tale of Three Cities: Racial and Ethnic Disparities in Premature Mortality in the District of Columbia, 2005
    • Product Recalls
    • Outrage: Big Tobacco Targets College Students

    September 2008, V24#9

    • Long-Term Care Insurance: Perennial Questions, Updated Answers
    • Product Recalls
    • Outrage: Athletic Prowess and the Doping of Consumers

    August 2008, V24#8

    • Unseen Payoffs and the Poverty of Prevention
    • Just How Does the U.S. Health Care System Stack Up?
    • Product Recalls
    • "Mistakes Were Made": Disclosing Medical Errors
    • Outrage: Botox, Mark Spitz, Nadia Comenici and Willie Nelson

    July 2008, V24#7

    • What Are Presidential Candidates (And Their Advisors) Talking About? Part II
    • Macular Degeneration
    • Product Recalls
    • Outrage: Why is Darvon (Darvocet/propoxyphene) Still Around, Hurting People?

    June 2008, V24#6

    • Drug Research: To Test or to Tout?
    • Backsliding on Childhood Immunizations
    • Public Citizen Urges Removal of Ortho-Evra Patch from Market
    • Product Recalls
    • Study Finds New Blood Substitutes Increase Risk of Death, Heart Attacks; Authors Question FDA’s Approval Process, Records Access
    • Outrage: Human Experimentation and Speedy For-Profit Ethical Review Boards

    May 2008, V24#5

    • Health Policy Placebos
    • Physician Support for National Health Insurance on the Rise
    • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2005-2007
    • Product Recalls
    • Outrage: "Physician, Heal Thyself" Not Always Simple

    April 2008, V24#4

    • Medical Errors and State Reporting of Adverse Events
    • Public Citizen Testifies on Drug Safety Before Congress
    • Product Recalls
    • Outrage: Unnecessary Medical Radiation: Children the Most Vulnerable

    March 2008, V24#3

    • Medical Records: Q&A
    • Public Citizen Launches Now Blog
    • Market-Based Failure: A Second Opinion on U.S. Health Care Costs
    • Product Recalls
    • Outrage: Scarce Kidneys: Why U.S. Transplantation Policies Are Inherently Inequitable and How They Can Be Changed

    February 2008, V24#2

    • Lost in Translation: Why the Highly-Touted Dutch Health System Would Not Be a Good Idea for the U.S.
    • Product Recalls
    • Outrage: Drug Industry Spends Almost Twice As Much on Promotion of Drugs As on Research

    January 2008, V24#1

    • Boundaries Without Barriers: Cross-Border Health in the European Union
    • Product Recalls
    • Health Letter Volume Index 2007 and Cumulative Index
    • Outrage: Pay for Performance: Incentives Gone Awry

    December 2007, V23#12

    • What Happened in U.S. Health Care in 2007?
    • Update on Avandia
    • Product Recalls
    • MedWatch
    • Outrage: Illegal Kickbacks From Artificial Knee and Hip Manufacturers to Orthopedic Surgeons

    November 2007, V23#11

    • Rethinking Health Care for the Elderly
    • More Than A Prayer for Single Payer
    • Product Recalls
    • Another U.S. Go-It-Alone Policy
    • Outrage: "Reminder Ads": Innuendo Minus Information

    October 2007, V23#10

    • Equal Pay for Equal Work? Not For Medicaid Doctors
    • Hoodia: Another Weight Loss Scam
    • Product Recalls
    • Research as Public Relations
    • Outrage: Are Hospitals Making Us Sicker?

    September 2007, V23#9

    • Improving Public Access to Clinical Trial Information
    • Scapegoating Immigrants
    • Product Recalls
    • The Latest Data on the Uninsured
    • Outrage: Manipulating the Hispanic Market: The Case of Viagra

    August 2007, V23#8

    • What Are The Presidential Candidates Talking About?: A Brief Dictionary of Health Policy Terms
    • Product Recalls
    • Now, Let the Victim Beware
    • Taming Technology
    • Outrage: Our Health Care System

    July 2007, V23#7

    • Q&A on the Human Papilloma Virus Vaccine Gardasil
    • Product Recalls
    • Organ Donations: What Price, The Priceless?
    • Taming the Giant Corporation
    • Outrage: PDUFA: Buying Votes, Selling Unsafe Products

    June 2007, V23#6

    • Public Citizen’s Ranking of State Medical Boards’ Serious Disciplinary Actions, 2004-2006
    • Product Recalls
    • Outrage: Avandia: Not-So-New News of Heart Problems With the Popular Diabetes Drug

    May 2007, V23#5

    • Back to Basics: Clean Water as a Medical Milestone
    • Doctors and Drug Company Favors
    • Drugs for Weight Loss
    • Product Recalls
    • Do Not Use Dextromethorphan
    • Outrage: What’s Wrong With This Story?: Pharmaceutical Company Files Sales Director for Telling the Truth

    April 2007, V23#4

    • Unsettling Scores: A Ranking of State Medicaid Programs
    • Product Recalls
    • Outrage: Walling Off Medicaid Beneficiaries

    March 2007, V23#3

    • Public Citizen Petitions FDA to Ban Third-Generation Oral Contraceptives
    • Product Recalls
    • Cough and Cold Meds Send Babies to Hospital
    • American Life Expectancy on Rise
    • Colds: How to Treat Them
    • Outrage: And The Oscar for Best Drugumentary Goes To…

    February 2007, V23#2

    • Medicaid @ 40: Why It Matters
    • Work and Wellness: Collusion or Collision?
    • A Statement by Dr. Sidney Wolfe, Health Letter’s Editor-in-Chief
    • Conflicts of Interest: An Issue That Will Not Go Away
    • Product Recalls
    • Conflicts of Interest Among Clinical Investigators
    • Outrage: Essay: What’s Making Us Sick Is an Epidemic of Diagnoses

    January 2007, V23#1

    • Dr. Wolfe’s Diet Revolution
    • Product Recalls
    • Health Letter Volume Index 2006 and Cumulative Index
    • Outrage: Conflicts of Interest: The Hidden Side of Science

    December 2006, V22#12

    • Report of Doctor Disciplinary Information on State Web Sites: A Survey and Ranking of State Medical and Osteopathic Board Web Sites in 2006
    • Product Recalls
    • What If We Were Equal?

    November 2006, V22#11

    • New York City’s Answer to the Diabetes Epidemic: Screen, Trace, Track and Act: More Public Health, Fewer Pharmaceuticals
    • A Broader Context: Diabetes in the United States and in the World
    • What is Diabetes?
    • Bogus Cures for Diabetes on the Internet
    • The New York City Department of Health’s Recommendations for Living with Diabetes
    • Product Recalls
    • Diabetes in the U.S.: The Epidemic in Numbers
    • Placing the Promise of Prevention in Context: The Case against the Diabetes Drug Rosiglatizone (Avandia) 

    October 2006, V22#10

    • Crime and Punishment, Medical Style
    • The US FDA at a Crossroads
    • No “Alternative”
    • Product Recalls
    • The Number of Uninsured in the United States Reaches 46.6 Million

    September 2006, V22#9

    • The Changing Dynamics of C-Sections in the United States: Cesarean Delivery on Maternal Request: Part II
    • Patients Without Borders:: The Emergence of Medical Tourism: Part II
    • The “Ultimate Prize” for Big Tobacco: Opening the Chinese Cigarette Market by Cigarette Smuggling
    • Product Recalls
    • Fairness Creams in South Asia: A Case of Disease Mongering?

    August 2006, V22#8

    • Health Care Reform in the United States: Arguments for a Single Payer System
    • The Changing Dynamics of C-Sections in the United States: Part I
    • Product Recalls
    • Pharmaceutical Marketing and the Invention of the Medical Consumer

    July 2006, V22#7

    • Patients Without Borders: The Emergence of Medical Tourism
    • Study Finds Many Favor A Single Payer System
    • Product Recalls
    • Much-Needed Corrective Lenses for the “Clinical Eye”
    • Laser Therapy for Smoking: Shining a Laser on Bad Advertising Practices
    • The Growing Gap in Reproductive Health

    June 2006, V22#6

    • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions: 2003-2005
    • Poll: People Understand Systemic Problems at FDA
    • Product Recalls
    • Exercise Status and Future Dementia
    • Study Finds Glucosamine, Chondroitin Ineffective for Joint Pain
    • Outrage: Pharmaceuticals Need Price Controls

    May 2006, V22#5

    • The Fight against Disease Mongering
    • From Unease to Disease
    • Blurring the Boundaries between Health and Illness
    • Product Recalls
    • Massachusetts’ Mistake

    April 2006, V22#4

    • Hearing Aids: Why Medicare Should Provide Coverage
    • Despite New Study, Crestor Should Not Be Prescribed
    • Product Recalls
    • Chromium Industry Withheld Data from OSHA
    • Outrage: Darvon and Darvocet: What Are They Thinking?

    March 2006, V22#3

    • Drugs Used to Treat High Blood Pressure
    • Elevated Cholesterol Levels
    • Who Needs Nondietary Potassium Supplementation?
    • Product Recalls
    • Outrage: Health Care Quality?

    February 2006, V22#2

    • High Blood Pressure
    • The High Cost of Cancer Treatment
    • Product Recalls
    • Preventing Dementia with Exercise
    • Outrage: Why Over-the-Counter? Diet Drug Poses Risks, Questionable Benefits

    January 2006, V22#1

    • Saving Money When Buying Prescription Drugs: Part III: Caution When Purchasing Drugs on the Internet
    • Recall Update
    • Product Recalls
    • Health Letter Volume Index 2004 and Cumulative Index
    • Outrage: Medicare Part D: What Benefit?

    December 2005, V21#12

    • Drivel from the Drug Industry/U.S. Government Axis
    • Saving Money When Buying Prescription Drugs, Part II: Generic Drugs
    • Product Recalls
    • Outrage: Second Chances: Big Tobacco Enters the Health Care Industry

    November 2005, V21#11

    • Curbing the Influence of the Drug Industry: A British View
    • Saving Money When Buying Prescription Drugs
    • Product Recalls
    • Public Citizen Writes of Drug Company Deception in Lancet Medical Journal
    • FDA Reverses Course of Needle Sticks, Shows Profound Indifference to Worker Health
    • Outrage: Helping Drug Reps Serve You Better: National Healthcare Census

    October 2005, V21#10

    • FDA Device Regulation Leaves Unsafe Products on Market: Public Citizen Petitions for Better Rules
    • Antibiotic Clarithromycin (BIAXIN) Can Have Deadly Interaction with Anti-Gout Drug Colchicine
    • Product Recalls
    • Three Misleading Direct-to-Consumer Ad Campaigns
    • Insurers Have it Wrong on Malpractice—Again
    • Industry Drug Guidelines Will Do Little to Prevent Misleading Ads

    September 2005, V21#9

    • New “Diseases”: Often Invented by Drug Industry Marketing Departments to Sell You Drugs
    • Ten Additional Causes of Medical Malpractice Lawsuits
    • Preventing the Epidemic of Skin Cancer: A Guide for Protecting Yourself and Your Family
    • Product Recalls
    • Asthma Medicines That Can Cause Asthma Attacks: Do Not Use Serevent, Advair, or Foradil
    • Outrage: FDA Denial of Public Citizen’s Petition to Ban Meridia is Misguided

    August 2005, V21#8

    • Sleight-of-Hand: Merck Contemplated Vioxx Reformulation in 2000 While Denying Risk
    • Can I Buy You Dinner? Pharmaceutical Companies Increasingly Use Doctors’ Talks as Sales Pitches
    • Product Recalls
    • Pennsylvania Data Show Large Number of Hospital-Acquired Infections
    • Decreased Child Mortality a Possibility with Appropriate Funding, Study Shows
    • FDA Issues Guidelines for Consumer Prescription Drug Information
    • FDA Approves Depression Device Without Proof of Effectiveness
    • Outrage: Warning: Contains FDA-Approved Drug…

    July 2005, V21#7

    • Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
    • Scientific Misconduct: Rare or Rampant?
    • Product Recalls
    • Successfully Pushing Paxil on Television
    • Outrage: Drug Rep (salesman) vs. Dr. Grobstein

    June 2005, V21#6

    • Ranking the State Medical Boards’ Serious Disciplinary Actions: 2002-2004
    • Product Recalls
    • Outrage: Repeat Malpractice Offenders Compromise Patient Safety

    May 2005, V21#5

    • In Memoriam: Bill Hines, 1917-2005
    • “…Makes You Stop and Think”
    • Product Recalls
    • HMO-Medicare Crisis: Is Health Insurance for the Elderly on the Way Out?
    • Outrage: The Causes of Misprescribing and Overprescribing

    April 2005, V21#4

    • George A. Silver, M.D., 1913-2005: In Memoriam
    • Misprescribing and Overprescribing of Drugs
    • Product Recalls
    • Outrage: The Problem Is…

    March 2005, V21#3

    • Medical Liability Reform? FDA Does Not Adequately Protect Consumers
    • Illness and Medical Bills Cause Half of All Bankruptcies
    • Product Recalls
    • Outrage: Get the Lead Out

    February 2005, V21#2

    • Nine Reasons Why Older Adults Are More Likely Than Younger Adults to Have Adverse Drug Reactions
    • Product Recalls
    • Bereavement
    • Outrage: Take Drugs Off the Market

    January 2005, V21#1

    • Health Care: Beyond Markets
    • Product Recalls
    • Health Letter Volume Index 2004 and Cumulative Index
    • Outrage: HHS Fails to Warn About Preventing Falls in Older Adults

    December 2004, V20#12

    • Single Payer: Good for Business
    • The View From Vermont

    November 2004, V20#11

    • America’s Neglected Veterans: 1.7 Million Who Served Have No Health Coverage
    • Blockbuster Arthritis Drug Rofecoxib (VIOXX) Withdrawn From Market: Worst Pills, Best Pills News Readers Warned in 2001: DO NOT USE
    • Screening for Colon Cancer: Insurance Coverage Still Spotty
    • “Stealth PACs” Give Drug Industry Big Bang for Its Bucks

    October 2004, V20#10

    • Cheap Trick: Bush’s health-savings accounts are a bargain—provided you never get injured or sick
    • You Have Reached the Medicare Program. Please Hold for the Next Available Source of Inaccurate Information.
    • Discovering Health Care Fraud and “Telling”: Whistleblowers  

    September 2004, V20#9

    • Blood Safety
    • Why is the U.S. So Far Behind on Prescription Drug Price Controls?
    • DO NOT USE! Lawsuit Reveals Serious Safety Problems With The Nonsteroidal Anti-inflammatory Drug (NSAID) Valdecoxib (BEXTRA)
    • Even Moderate Amounts of Exercise Can Prevent Weight Gain
    • DO NOT USE! Long-Term Treatment with The Alzheimer’s Disease Drug Donepezil (ARICEPT) Ineffective
    • Weapons of Mass Destruction and Medicine

    August 2004, V20#8

    • The People Have Spoken: The Drug Industry Doesn’t Serve Us Well
    • Boutique Medicine (Concierge Care) Revisited
    • Doctor Bribing in Italy
    • Suicide Risk Added To The Professional Product Labeling For Eight Antidepressants
    • DO NOT USE—Save Your Money: Dextromethorphan (DELSYM or generic) Or Diphenhydramine (BENADRYL or generic) Ineffective for Nighttime Cough in Children
    • Outrage: Medizine: Drug Ads Masquerading as News

    July 2004, V20#7

    • The High Costs of For-Profit Care
    • It Takes Two to Tango (or to Bribe): Big-Time Crime in the Pharmaceutical Industry with the Help of Doctors
    • Regular Exercise May Prolong Your Life
    • The Wild, Wild Web for Prescription Drugs
    • Outrage: Breast Implants as High School Graduation Presents: Just Poor Parenting or Child Abuse?

    June 2004, V20#6

    • Patent Fiction
    • National Health Insurance: Falling Expectations and the Safety Net
    • DO NOT USE! Dangerous Drug for Irritable Bowel Syndrome: Constipation Predominant Tegaserod (ZELNORM)
    • Improper Antibiotic Treatment for Bladder Infections
    • Outrage: Serious and Growing Problem of Antibiotic Resistance

    May 2004, V20#5

    • Public Citizen’s Health Research Group Ranking of State Medical board Serious Disciplinary Actions in 2003
    • The Antidepressant Fluoxetine (PROZAC) and Suicidal Ideation—Déjà vu 1991
    • Saline Spray: Do Try This at Home
    • Outrage: FDA Frustrates the Intent of Congress for 17 Years

    April 2004, V20#4

    • Prescriptions and Profit
    • Publicity about Recent Studies on the Cholesterol-lowering Statin Drugs: Misinterpretations
    • Direct-to-Consumer Advertising: Bad News for Most Patients and Doctors
    • Comments of a Canadian Doctor: After 10 years, has anything really changed for the better?
    • Outrage: Serious Concerns about a Portable Ventilator (respirator)

    March 2004, V20#3

    • Overselling Donepezil (ARICEPT) and Exploiting Patients with Alzheimers Disease: Why Isn’t The FDA Stopping These Ads?
    • New Jersey Slow to Police Problem Physicians
    • Outrage: Kidney Dialysis Facilities: Serious Problems of Compliance with Medicare Quality Standards

    February 2004, V20#2

    • Study Shows National Health Insurance Could Save $286 Billion on Health Care Paperwork
    • Product Recalls
    • Canada Outdoes U.S. on Flu Vaccine Policy
    • How to Achieve Positive Results Without Really Lying
    • Outrage: AARP and Medicare Legislation

    January 2004, V20#1

    • Breast Cancer: New Information About Screening Mammography and Genetics
    • Product Recalls
    • Health Letter Volume Index 2003 and Cumulative Index
    • Outrage: National Institute of Mental health Fails to Fund Important Mental Health Research

    December 2003, V19#12

    • Documentary Shows Problems in Pharmaceutical Industry, FDA
    • Product Recalls
    • FDA Issues Public Health Advisory On Antidepressants and Suicide Risk in Children
    • How to Report Adverse Reactions to the FDA
    • Outrage: Do Not Use: Dangerous Antidepressant Nefazodone (SERZONE) Withdrawn From the Market in Canada

    November 2003, V19#11

    • A Conversation With Sheldon Krimsky: Uncoupling Campus and Company
    • Advertising Dietary Supplements on the Internet: Supplementing Income Rather than
    • Health
    • Product Recalls
    • Do Not Use: Asthma Drug Montelukast (SINGULAIR) for the Treatment of Hay Fever
    • Outrage: We Have Met the Enemy and He is Us

    October 2003, V19#10

    • A New Health Care Gimmick: Concierge Medicine
    • Do Not Use: Rosuvastatin (CRESTOR) — A New But More Dangerous Cholesterol-Lowering “Statin” Drug
    • A Reminder About the Dangerous of Aspirin and Reye’s Syndrome
    • Product Recalls
    • Meridia — Weight Loss or Health Loss?
    • Outrage: Food and Drug Disaster

    September 2003, V19#9

    • Sweetening the Pill
    • CPSC Says Consumers Continue to Use Dangerous Products Despite Recalls, Warnings
    • Product Recalls
    • Outrage: FDA-Approved Patient Information Needed

    August 2003, V19#8

    • Profitably Inventing New Diseases The pharmaceutical industry cashes in by "creating" diseases
    • Secret No More Medicare investigation results now fair game
    • Product Recalls From sunscreen to extension cords: watch out!
    • Bad Medicine Why Bush's malpractice policy will only help insurers
    • Outrage of the month Taxol: How the NIH gave away the store

    July 2003, V19#7

    • The Big Fix: A Book Review: How the pharmaceutical industry rips off American consumers
    • Product Recalls
    • Outrage of the Month: How Bayer shipped HIV-containing blood products to Asia and Latin America

    June 2003, V19#6

    • Doctor, Advocate, Activist
    • Health Research Group Ranks Medical Boards
    • Product Recalls
    • Resisting Antibiotic-Resistant Bacteria
    • Outrage: Democracy by Disclosure: A Book Review

    May 2003, V19#5

    • Ephedra: Scientific Evidence Versus Money/Politics
    • Calcium By Any Other Name is Still Calcium
    • Bereavement
    • Product Recalls
    • Outrage: The Uncovering of an Undercoder: A Story of Medicine Triumphant

    April 2003, V19#4

    • Cost, Quality and Choice: Winning Less Expensive, Better Quality Health Care For America
    • Affordable Reform That Benefits Patients
    • The Dangers of Some Screening Tests
    • A Free Ride for Bad Doctors
    • Product Recalls
    • Outrage: Nexium Offers Unique Advantage Over Generic Omeprazole

    March 2003, V19#3

    • Selling "New" Drugs Using Smoke and Mirror (Images)
    • Foggy Thinking as Inhaled Flu Vaccine Nears FDA Approval
    • Product Recalls
    • MedWatch Reporting Form
    • Outrage: U.S. Air Force Flies High on Dexedrine

    February 2003, V19#2

    • Medical Errors, Not Lawsuits, are Real Cause of Rising Malpractice Insurance Premiums
    • Inadequate Doctor Discipline by State Medical Boards
    • Government Publishes Adult Immunization Schedule
    • Product Recalls
    • Tamoxifen for Breast Cancer Prevention?
    • Outrage: Wanna Quit Smoking? Who you Gonna Call? Philip Morris?

    January 2003, V19#1

    • "Neglected to Death:" The Scandalous Condition of American Nursing Homes
    • Product Recalls
    • Phyllis McCarthy Annual Public Interest Award
    • Health Letter Volume Index, 2002 and Cumulative Index
    • Remedies Needed to Address the Pathology in Reporting Adverse Reactions and Food and Drug Administration Use of Reports

    December 2002, V18#12

    • 25,00 U.S. Deaths a Year Because of For-Profit Kidney Dialysis
    • Low Quality HMOs Hide Performance Data from Public, Says Journal of the American Medical Association Study
    • Blind to the Data: OSHA Looks the Other Way as Workers Exposed to Hexavalent Chromium
    • Product Recalls
    • Drug Safety Withdrawals: Who is Responsible for Notifying Patients?
    • "Dangerous Political Cowardice:" FDA Fails to Ban Dietary Supplement Ephedra
    • Outrage: The Corruptible Academic-Industry Partnership

    November 2002, V18#9

    • Unsafe Drugs: Congressional Silence is Deadly (Part 2)
    • FDA Caves In to Industry, Fails to Adequately Address Tylenol Overdoses
    • Product Recalls
    • High Blood Pressure in the Physician’s Office?
    • Alzheimer’s Disease: Major Market Here to Stay
    • Outrage: GAO Report Backs Link Between Drug User Fees and Higher Rate of Drug Withdrawals

    October 2002, V18#8

    • ADAPT Trial for Alzheimer’s Disease Prevention Should Be Canceled
    • Will a Vitamin a Day Keep the Doctor Away?
    • Questionable Doctors Online
    • Product Recalls
    • Outrage: Strange Bedfellows: How the Tobacco and Drug Industries Collaborated to Undermine Anti-Smoking Efforts

    September 2002, V18#8

    • The Invisible Plague: The Rise of Mental Illness from 1750 to the Present
    • Update on the Illegal Promotion of Gabapentin (Neurontin)
    • Product Recalls 
    • Pressure On to Ban Ephedra
    • West Nile Virus Activity
    • Outrage: Health Research Group Asks for Metabolife President to be Investigated

    August 2002, V18#8

    • Ethical Implications of Cosmetic Surgery for Aging
    • Product Recalls
    • Is Your Doctor Selling You to the Highest Bidder?
    • Hormone Replacement Therapy
    • Outrage: "It’s Botox Night at Hopkins"

    July 2002, V18#7

    • Big Pharma Buys Psychiatry: An Aura of Scandal
    • Product Recalls
    • Conflict of Interest?
    • Nicotine Lollipops: Sweet, Addictive and Illegal
    • Cancer.gov
    • Ten Years Ago Today
    • Outrage: Department of Health and Human Services Fails to Ban Ephedra or Issue Adequate Warnings

    June 2002, V18#6

    • Questionable Doctors Online: Disciplined Doctor Resource Debuts on Public Citizen Web Site in June
    • Understanding Risks — and the Risks You Run by Misunderstanding Them
    • Overworked Doctors Walk Off the Job
    • Product Recalls
    • Preventing Heat Induced Death and Illness
    • Outrage: New Study: Wait Seven Years to Use New Drugs

    May 2002, V18#5

    • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions in 2001
    • Survey of Doctor Disciplinary Information on State Web Sites
    • Product Recalls
    • Outrage: Possible Corruption at the American Heart Association

    April 2002, V18#4

    • Saving Your Sight — Early Detection is Critical
    • Nursing Homes: More Can Be Done to Protect Residents from Abuse
    • Product Recalls
    • Outrage: No Care for the Care Givers

    March 2002, V18#3

    • Direct-To-Consumer Advertising — Education or Emotion Promotion?
    • Analysis: HMOs Try New Approach to Keep Drug Cost Down
    • Rx Needed for Medical Journals
    • Product Recalls
    • Outrage: We Wish this Hospital Well

    February 2002, V18#2

    • The Destruction of Medicine by Market Forces: Teaching Acquiescence or Resistance and Change?
    • Good Business Suggestions [Business Week on controlling drug costs]
    • Product Recalls
    • Health Research Group Asks New Mexico to Sanction Doctor
    • New Study Shows Low Income Minority Seniors Restrict Use of Prescription Drugs
    • What Ails the Mass. Board of Medicine?
    • FDA Action on Red Cross Long Overdue
    • Canadians Begin Recall of Dangerous Drug Supplement Ephedra
    • Outrage: The AMA Does It Again

    January 2002, V18#1

    • What’s New In Screening Mammography
    • Product Recalls
    • Clearing the Smoke from Low-Tar and Nicotine Cigarettes
    • Health Letter Volume Index 2001 and Cumulative Index
    • Outrage: Oops — Did It Again (or, Escondido in Escondido)

    December 2001, V17#12

    • "You Can’t Leap a Chasm in Two Jumps"
    • Product Recalls
    • "...Makes You Stop and Think!"
    • Philip Morris Brags About its Killer Cigarettes
    • Living and Dying
    • DEA Promotes Public Citizen Information
    • Outrage: "I Have Never Seen Anything Like This"

    November 2001, V17#11

    • Insufficient Credits
    • Drugs for Possible Exposure to Anthrax: What Makes Sense?
    • An Epidemic of Lung Disease Caused by a Quarter-Century of Government Inaction
    • Product Recalls
    • Colds: How to Treat Them
    • Outrage: The Lupron Loophole — and the Doctors Who Exploited It

    October 2001, V17#10

    • Health Care Reform Coming? Don’t Bet the Farm On It
    • Unsafe Drugs: Congressional Silence Is Deadly
    • Product Recalls
    • Outrage: Do Not Use Ephedra

    September 2001, V17#9

    • Criminal Charges Should Be Filed Against Schering-Plough
    • Direct-to-Consumer (DTC) Ads: Illegal, Unethical or Both
    • Below the Beltway
    • Product Recalls
    • Outrage: Crouching Government, Hidden Snake Oil

    August 2001, V17#8

    • In Memory of Our Colleague Henry Bergman
    • Questionable Hospitals
    • Product Recalls
    • Outrage: Darvon, Darvocet, Darvon Compound

    July 2001, V17#7

    • Hormone Therapy: Doubts Grow
    • Drug Companies’ Antics Can Really Make You Sick
    • Product Recalls
    • Why Doesn’t the Government Know About These Doctors?
    • Outrage: "Operation Cure.All" Wages New Battle in Ongoing War Against Internet Fraud

    June 2001, V17#6

    • Public Citizen Petitions OSHA to Limit Residents’ Working Hours
    • Preventing Heat-Induced Death and Illness
    • Product Recalls
    • Outrage: Lontronex and the FDA: A Fatal Erosion of Integrity

    May 2001, V17#5

    • Public Citizen’s Health Research Group Ranking of State Medical Board
    • Disciplinary Actions in 2000
    • How to Reduce the Risk of Mad Cow Disease in the United States
    • Product Recalls
    • Outrage: Dietary Supplements: The FDA Should Do More

    April 2001, V17#4

    • Latin America: the Answer to Drug Companies' Problems?
    • Election 2000 Commentators
    • Product Recalls
    • One Drug Company -- Shering-Plough -- Faces Massive Recalls
    • High Drug Prices for Research or Profit?
    • Is This Doc Deadly? His Practice Hasn't Been Perfect
    • Outrage: CASHCOW -- Here a Moo, There a Moo

    March 2001, V17#3

    • Is the U.S. Safe from Mad Cow Disease? Could We Be Safer?
    • Still Hard to Swallow
    • Product Recalls
    • It's the Calories that Count
    • COX-2 Inhibitors Vioxx and Celebrex: Keep Staying Away
    • Consumer Product Safety Commission Finally Sees the Light on Lead in Candles
    • Outrage: A Discussion of Misleading Drug Ads

    February 2001, V17#2

    • Unhealthy Partnership: How Massachusetts and Its Managed Care Contractor Shortchange Troubled Children
    • Bad Policy, Worse Medicine
    • Let the ‘Non-Governments' Beware: Multinational Organizations Are Out to Co-opt You and Your Tactics
    • Product Recalls
    • Outrage: None of Your Business

    January 2001, V17#1

    • FDA Fails to Get the Point on Safe Needles for Health Care Workers
    • Sex Education Information on the Internet: Caveat Emptor!
    • Product Recalls
    • Volume Index, 2000 and Cumulative Alphabetic Index
    • Outrage: FDA Accuses Red Cross of Jeopardizing the Safety of the Blood Supply

    December 2000, V16#12

    • Is U.S. Health Really the Best in the World?
    • Osteoporosis
    • A Better Quality Alternative: Single Payer National Health Reform
    • Medical Fluoroscopy: Radiation-induced Skin Injury
    • Product Recalls
    • Outrage: America's Ailing Medical Education System

    November 2000, V16#11

    • Review of Calcium Supplements; Ads Exaggerate Differences
    • Long-Acting Calcium Channel Blockers Inferior to Older Blood Pressure
    • Lowering Drugs in Preventing Heart Attacks and Heart Failure
    • When is a Patient Group Not a Patient Group?
    • Product Recalls
    • Television and Obese Children: A Strong Connection
    • Sitting Backwards is Safer
    • HRG Petitions the FDA to Ban Dangerous Diet and Cough/Cold Drugs in Over-the Counter Products
    • Outrage: "Too Much Corporate Power"

    October 2000, V16#10

    • Epilepsy
    • How To Report Adverse Reactions to the Food and Drug Administration
    • Product Recalls
    • Outrage: Victimizing the Vulnerable

    September 2000, V16#9

    • 20,125 Questionable Doctors
    • Product Recalls
    • Outrage: Human Experimentation for Profit

    August 2000, V16#8

    • The Pharmaceutical Industry--To Whom is It Accountable?
    • Hundreds of Thousands of Workers at Risk from Hexavalent Chromium, Study Obtained Through FOIA Shows
    • Product Recalls
    • Report Estimates Air Lead Levels from Some Candle Wicks at Up to 36 Times EPA Standards
    • The Risks of Tranquility
    • Outrage: Erroneous and Misleading Reports in Media About Prescription Drugs

    July 2000, V16#7

    • Patients' Rights Bills
    • Bereavement
    • Product Recalls
    • Outrage: Inspector General's Study on Human Experimentation

    June 2000, V16#6

    • Kids First? How Vaccination Politics Can Undermine Public Health
    • Product Recalls
    • eLetter Web Site Launched on Drugs for the Seriously Mentally Ill
    • Doctors or Nurses - Does it Really Make a Difference?
    • Summer: How to Protect Yourself
    • Dangerous Gap in the Drug Safety System
    • Canadian Update on the Drug Celecoxcib (CELEBREX) Confirms HRG Warning
    • Outrage: Mother Dies, But Son Can't Get Explanation Because Her Doctor Won't OK Inquiry's Disclosure

    May 2000, V16#5

    • Ranking of State Medical Board Disciplinary Actions in 1999
    • Do Not Use This Drug: Propulsid Withdrawn from the Market
    • Product Recalls
    • Loyalty in Government Service - to Whom?
    • Reducing Dangers to Pregnant Women
    • Outrage: Drkoop.CON: America's Family Doctor and his Conflicts of Interest, Part II

    April 2000, V16#4

    • Safety Alert! It Is Better to Curse the Darkness Than to Light This Kind of Candle
    • St. John's Wort: A Growing List of Harmful Drug Interactions
    • Medicare: Few Beneficiaries Use Colorectal Cancer Screening and Diagnostic Services
    • Product Recalls
    • Patients, Doctors Not Warned of Dangers of New Diabetes Drugs
    • Outrage: Health News Feels the Censor's Knife

    March 2000, V16#3

    • Survey of Doctor Disciplinary Information on State Medical Board Web Sites
    • Untested Herbs and Food Supplements for Pregnant Women Making the FDA Retract its Dangerous Regulation
    • Product Recalls
    • New Concerns About Menopausal Hormones and Breast Cancer
    • Outrage: The Unkindest Cut of All: Unnecessary Episiotomies

    February 2000, V16#2

    • Managed Costs, Mismanaged Care
    • Primary Care in the United States - The Best of Times, the Worst of Times
    • Trust Me, I'm a Patient
    • Hollywood Hails a Tobacco Whistle Blower
    • Product Recalls
    • Debate on FDA's Recent Decision on Herbal Products
    • Outrage: Flu Epidemic May Be Just a Flu Advertisement

    January 2000, V16#1

    • Wrong Prescription: Bill Bradley's Health Plan is No Cure
    • For-Profit Kidney Dialysis Centers Compromise Kidney Care
    • Point/Counterpoint: Is it Ethical to Pay Research Subjects Large Sums?
    • Product Recalls
    • Health Letter Volume Index for 1999 and Cumulative Index for 1985-1999
    • Outrage: Study Shows Widespread Medical Errors

    December 1999, V15#12

    • ‘Hope Lodge' Movement Offers Hope to Cancer Patients Away from Home
    • Medical Merger
    • Product Recalls
    • The Grass Really is Greener to the North
    • Important Safety Reminder - Reye's Syndrome and Aspirin
    • Some More Questions About Your HMOs
    • The Science of Arresting Human Intelligence Long Enough to Get Money from It
    • Outrage: Milton, Matthew and Managed Care

    November 1999, V15#11

    • Losing Weight: The Truth is Hard to Swallow
    • Product Recalls
    • Another Medical Myth Laid to Rest
    • Outrage: Bradley and Gore Rehash Stale Ideas

    October 1999, V15#10

    • Clinton Administration Scuttles Worker Protections
    • An Interview with Breastfeeding Advocate and Formula Fighter Bobbi Philipp, M.D.
    • "Try It, You'll Like It" - For a Hefty Price: The Drugmaker's Scam on the Public
    • When Money is the Mission - The High Costs of Investor-Owned Care
    • Product Recalls
    • Outrage: Doctors and Rexall Combine to Push Worthless Dietary Supplements to Patients

    September 1999, V15#9

    • Fraudulent Health Claims: Don't Be Fooled
    • Product Recalls
    • Off-Label Dangers
    • Young Children Continue to Die Unnecessarily on U.S. Farms
    • Outrage: Pfizer Caught Trying to Subvert National Guidelines for Treating Children's Ear Infections

    August 1999, V15#8

    • Below the Beltway
    • Second Opinion: Temptation Makes a House Call
    • Product Recalls
    • Health Talk: Doctors Online
    • Worse Quality Medical Care in For-Profit HMOs Than in Not-for-Profits
    • Outrage: Dr. Koop: Part I

    July 1999, V15#7

    • Preventing Heat-Induced Death and Illness
    • The Wild, Wild Web
    • Safety of Speedy FDA Drug Approval Being Questioned
    • Asleep on the Job
    • Product Recalls
    • Workplace Deaths: Where is the Federal Prosecution of Employers?
    • Outrage: Star Wars and Drugs

    June 1999, V15#6

    • Public Citizen's Health Research Group Petitions the FDA to Revise Labeling on the Breast Cancer Drug Tamoxifen (NOLVADEX)
    • In the Public Interest
    • In Memoriam: John O. Nestor, M.D.
    • Product Recalls
    • Dangerous Drug Information on the Internet from Aetna/US Healthcare and Johns Hopkins
    • Outrage: Prescription Drug Profiles --- Accessible to All?

    May 1999, V15#5

    • Public Citizen's Health Research Group Ranking of State Medical Board Disciplinary Actions in 1998
    • International Research Ethics Code Under Siege
    • Notes from Sidney Wolfe's Mom
    • Nurses, Patients and Managed Care
    • Product Recalls
    • Outrage: The Troglitzone (Rezulin) Safety Meeting

    April 1999, V16#4

    • Adverse Drug Reactions
    • Crazy About Sex [Problems]
    • Preventing Osteoporosis, Falls and Fractures in Older Adults
    • Medicare Must Cover Prescription Drugs and Control Prices
    • The ACLU's Tobacco Addiction, Continued
    • Product Recalls
    • Outrage: Lessons from the George Lundberg Firing

    March 1999, V15#3

    • The New Edition of Worst Pills, Best Pills
    • Serious Health Insurance Problems
    • Exhaustion that Kills
    • Product Recalls
    • Outrage: The FDA and Abbott Are Comfortable

    February 1999, V15#2

    • "Going Bare": Uninsured Portion of U.S. Population Is Growing Rapidly, Survey Discloses
    • The Drug Approval Process
    • Product Recalls
    • A Dirty Little Secret: Managed Care is Bad of Business
    • Outrage: One More Hoax: The Neediest Would Get No Benefit from Clinton's Proposed Tax Credit

    January 1999, V15#1

    • FDA Medical Officers Report Lower Standards Permit Dangerous Drug Approvals
    • Healthy Patients and Wealthy HMO Stockholders: An Impossible Mix
    • Product Recalls
    • Health Letter Volume Indices, 1997 and 1998
    • Health Letter Cumulative Alphabetical Index
    • Outrage: Andy Rooney: The Tobacco Deal

    December 1998, V14#12

    • FDA's Controversial Decision: Tamoxifen (Nolvadex) Approved to Reduce the Risk of Breast Cancer HMO Medicare Crisis: Is Health Insurance for the Elderly on the Way Out?
    • Just Health Care
    • Product Recalls
    • Outrage: The ACLU's Tobacco Addiction

    November 1998, V14#11

    • Inequities Documented in Medicare's Kidney Transplant Program
    • Effects of Anti-theft and Metal Detector Systems on Some Medical Devices
    • The Pitfalls of Untested "Alternative Medicine" Remedies
    • Product Recalls
    • What Role for Chiropractic in Health Care
    • Outrage: Number of Americans Without Health Insurance Jumps to 43.2 Million

    October 1998, V14#10

    • U.S. Multinational Tobacco Companies' Double Standards Exposed
    • Health Letter 10 Years Ago
    • Product Recalls
    • Don't be a Casualty on the Information Super Highway
    • Major Access Barriers Identified in 10-State Health Insurance Study
    • Outrage: Merck Drug, Mark McGwire and Barbecue

    September 1998, V14#9

    • Toward Universal Coverage
    • Breast Implants: The Debate Continues
    • Which Side of the Street is the AMA Working?
    • International Comparison of Drug Prices
    • Product Recalls
    • Outrage: Maliciously Blurring the Line Between News and Advertising

    August 1998, V14#8

    • Public Citizen's HRG Petitions the FDA about Sildenafil (Viagra)
    • Product Recalls
    • Focus: Rush to Market
    • Medical Horror Stories: A Sign of a Health Care System in Crisis

    July 1998, V14#7

    • Worst and Best Types of HMOs
    • Product Recalls
    • Outrage: Dangers to Participants in Human Experimentation

    June 1998, V14#6

    • Cataracts In Adults: A Patient's Guide
    • Cataract Surgery Is This Trip Really Necessary?
    • Product Recalls
    • Preventing Heat-Induced Death and Illness
    • Doctors Need Patient's Help to Report Adverse Reactions to Drugs and Devices
    • Outrage: High-Heeled Shoes -- An Important Health Hazard

    May 1998, V14#5

    • Public Citizen Health Research Group Ranking of State Medical Board
    • Disciplinary Actions in 1997
    • Dozens of Thai Infants Were Needlessly Infected with HIV in Unethical U.S. Govt-Funded Study
    • Product Recalls
    • Making A Difference: Can One Lone Consumer Persuade a Major Pharmaceutical Company to Change and Improve its Product?
    • Call For a Doctor! And Call...and Call...and Call
    • Switching Sides
    • Outrage: American Cancer Society and American Health Association

    April 1998, V14#4

    • Prescription for Privacy
    • Private Care in Canada
    • Product Recalls
    • Aging and Your Eyes
    • Outrage: Questionable Doctors in Your HMO

    March 1998, V14#3

    • 16, 638 Questionable Doctors
    • Health Insurance: Physical Abnormalities as Barriers to Treatment
    • Product Recalls
    • Access to Health Care: Some Nibbles and a Bite
    • Criminalizing Medical Malpractice
    • Is It Time to Quit the AMA?
    • Nutri/System Diet Clinics -- Dealing Diet Drugs

    February 1998, V14#2

    • Powdered Latex Gloves Pose Serious Risk
    • An Appreciation: Esther Peterson 1906-1997
    • Product Recalls
    • Grim Details Under the Headlines
    • First, Do No Harm (Pending Prior Approval)
    • Unproven "Anti-Aging" Hormones Promise Youth
    • Bone Up! Choose Foods that are High in Calcium
    • Outrage: Direct-to-Consumer Hucksterism

    January 1998, V14#1

    • Hospital Emergency Rooms and Patient Dumping
    • For Patients, Not Profits
    • Product Recalls
    • Bugs Causing Food Poisoning
    • Health Letter Indexes
    • Outrage: There They Go Again: The Joint Commission Protects Potentially Dangerous Hospitals

    December 1997, V13#12

    • Long-Term Care Insurance: To Buy or Not To Buy, That is the Question
    • Who Poisoned the Children?
    • Stings and Strings: One Couple's Struggle with a Health Plan's Gatekeepers
    • Qui Tam: "Whistle-Blower" Lawsuits Recover Government Health Care Dollars
    • Product Recalls
    • Outrage: The "Benefits" of Sterility-Causing Chemicals in the Workplace?

    November 1997, V13#11

    • Stadol -- User Beware
    • FTC Consumer Alert; Paunch Lines: Weight Loss Claims Are No Joke for Dieters
    • FDA Alerts: The Stimulator; Home-Use Test Kits
    • First, Do Nothing: Harvard Docs Announce "HMO Black"
    • Product Recalls
    • Managed Care: Doctors' Perspectives
    • Outrage: Columbia/HCA's Response to a Patient's Death: "You Know, We All Are Going to Die"

    October 1997, V13#10

    • Experts Urge Steps to Stem Antibiotic Resistance
    • Budget Balancing: Medicare Savings, Medicaid Savings, and Other Shenanigans
    • Prescription for Trouble
    • If you Thought Our Health Care System Was Doing O.K., Note Some Contributions from Our Readers
    • Product Recalls
    • Outrage: "Whistle-Blower" Lawsuits Continue to Recover Millions of Health Care Dollars for the Government

    September 1997, V13#9

    • HMO's Arbitration Process Provides Delay, Not Justice
    • The HMO That Ate the High School
    • Managed Care vs. Medical Care
    • Protecting the Corporate Bottom Line: The Narrow Therapeutic Index (NTI)
    • Drug Scam
    • Health Risks of the Internet
    • Product Recalls
    • Outrage: AMASCAM

    August 1997, V13#8

    • Health Care, Will Care Be There?
    • The Politics of Mammography
    • Abnormal Moles Found to Increase Risk for Melanoma
    • Hormones: Correction and Additions
    • Product Recalls
    • Outrage: Booze, Pool and (??) School

    July 1997, V13#7

    • Physicians Disciplined for Sex-Related Offenses
    • Long Term Care: Who Pays? The New Laws
    • Doctor-Run HMOs
    • Product Recalls
    • Outrage: Another Insurance Company Story

    June 1997, V13#6

    • Sometimes Mother Nature Knows Best
    • Snapshots of Our Health Care System
    • Physician-Induced Hospitalization
    • Drugs: Over-the-Counter and On the Street
    • Product Recalls
    • Outrage: Halt 'Unethical' HIV Experiments Abroad Public Citizen Exhorts HHS Head Shalala

    May 1997, V13#5

    • Ranking of State Medical Licensing Boards -- 1996
    • Growing Number of Investigations Focus on Questionable Practices by Columbia/HCA
    • Health Care: Coping with Terminal Illness: A Personal Perspective
    • Product Recalls
    • Medigap Insurance: Consumer Choice, Consumer Dilemma
    • Outrage: Idaho: Dangerous Delays in Doctor Discipline

    April 1997, V13#4

    • For-Profit Hospitals Costlier, Less Efficient and Spend Less on Patient Care
    • Qui-Tam Lawsuits Recover Millions of Health Care Dollars for the Government
    • Study Finds High Incidence of Serious Errors in Hospitals
    • Frequently Asked Questions About Health Care
    • Product Recalls
    • Diversity in Doctors Providing Quality and Accessible Care for All
    • Birth Control Pills and Emergency Contraception
    • Outrage: Another Chicken Guarding Another Group of Foxes

    March 1997, V13#3

    • Annotation: Patients on the Auction Block
    • HMO: Managed or Mangled?
    • Product Recalls
    • Mergers, Buyouts: A Tale of Three Cities
    • Pet Cemetery?
    • Outrage: The Health Insurance Industry's Dirty Little Secret

    February 1997, V13#2

    • License to Steal: Why Fraud Plagues America's Health Care System
    • Michigan Orders Golden Rule to Issue Refunds
    • A Tragic Insulin Overdose
    • Diabetes: Insurance Coverage
    • The Changing Ways of the HMO Industry: Staff-and Group-Model HMOs Are Finding It Harder to Compete
    • Medical Discipline: Shroud of Secrecy
    • Welcome to Managed Caring®
    • Median Income for Doctors Hits $160,000 in 1995
    • Consumer Product Safety Alert
    • Food Labeling: Consumer Alert
    • Outrage: California HMO Fined $500,000 for Failing to Refer Patient to Specialist

    January 1997, V13#1

    • Book Review: How HMOs Are Destroying Medical Trust
    • Do Not Ask for Whom the HMOs Merge...
    • Drug Recalls
    • Health Letter Indexes: Volume Index 1995 and 1996; Cumulative Subject Index
    • Outrage: There are Few Willing to Fight the Rampaging HMO Monsters

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.